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Endocrine disruptionBisphenol A (BPA), a widespread Endocrine Disrupter mainly used in food contact plastics, may induce adverse
effects especially on susceptible lifestages, ﬁrst of all pregnancy. The present study considered placental develop-
ment as a potential target of BPA and investigated potential differences in themodes of action of two doses of BPA
by a toxicogenomic approach. Pregnant CD-1 mice were administered with vehicle, 0.5 (BPA05) or 50 mg/kg
(BPA50) body weight (bw)/die of BPA, from gestational day (GD) 1 to GD11. At GD12 dams were sacriﬁced
and transcriptomic analysis was performed on placenta samples. Histological, histomorphometrical and immu-
nohistochemical analyseswere also performed to phenotypically anchor transcriptional changes associatedwith
BPA exposure. The interpretation and description of the overall data are included in a manuscript under revision
[1]. Herewe describe the experimental design and the analysis performed on the gene expression datawhich are
publicly available through the Gene Expression Omnibus (GEO) database with accession number GSE63852.
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Animal treatment
CD1 female mice (30–35 g bw) were purchased from Harlan (Italy)
and kept under standard laboratory conditions (22 ± 0.5 °C, 50–60%
relative humidity, 12 h dark–light alternation with 12–14 air changes/h)
with water and food (4RF25 GLP “Top Certiﬁcate” diet purchased
from Mucedola, Milan, Italy) available ad libitum. After 1 week of
acclimatization, females were bred with CD sires of proven fertility.
A sperm-positive vaginal plug served to deﬁne the Gestational day
(GD) 0. Pregnant mice were treated daily p.o. by gavage with 0 (vehicle
only=olive oil; Sigma-Aldrich,Milan, Italy), 0.5 or 50mg/kg bwprodie
of BPA (CAS no. 80-05-7, purity ≥99%, Sigma-Aldrich), named BPA05
and BPA50 respectively, dissolved in olive oil, from GD1 to GD11, a
period covering implantation through early placentation phase. On GD
12 the dams were sacriﬁced by asphyxiation with CO2, followed by
cervical dislocation. Four placentae per litter/group were ﬂash frozen
in liquid nitrogen then stored at−80 °C. The remaining placentae
were excised and ﬁxed for histological, histomorphometrical and
immunohistochemical analyses.
RNA extraction
Placenta samples were homogenized and total RNA was extracted by
using the RNAeasy Mini Kit (QIAGEN), containing β-mercaptoethanol
diluted 1:100. RNA quantity was assessed with NanoDrop (NanoDrop,
Wilmington, DE, USA), purity was assessed by UV absorbance ratiothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Boxplots of signal intensities by array before (A) and after (B) normalization within (Loess) and between (quantile) arrays.
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by 1% agarose gel electrophoresis.
Microarrays
cDNA and cRNA synthesis, ampliﬁcation and labeling were
performed using the Quick Amp Labeling Kit, Two Colors (Agilent,
Santa Clara, CA, USA) with spike-in internal controls (Agilent)
following manufacturer's protocol. Labeled samples and controls were
co-hybridized following a dye swap experimental protocol (control
and treatment samples alternatively labeled with Cy5 and Cy3) on
Agilent 4 × 44K Whole Mouse Genome Microarray G4122F at 65 °C
for 17 h, with a 10 rpm rotation in an Agilent Hybridization Oven.Fig. 2. Venn Diagram of differentially expressed genes in BPA05 and BPA50 mice placenta
with respect to control placentas.After washing with Gene expression wash buffers (Agilent), slides
were scanned by the Agilent G2505B Microarray Scanner System,
extracting data through the Agilent Feature Extraction 9.5 software.
All arrays met the minimum Agilent QA/QC standards.
Data analysis
Normalization and differential expression analysis were performed
using the R Bioconductor package limma [2–4]. Data were log2 trans-
formed (Fig. 1A) and background subtracted, then a global Loess was
performed to normalize each array. A quantile between-array normali-
zation was performed to obtain the same distribution of probe signal
intensities across arrays (Fig. 1B). Geneswith log2ﬂuorescence intensity
values (A) b6 were excluded. Arrays quality was also evaluated [5] and
obtained array weights were applied to the statistical model, a simple
linear model ﬁt and moderated t-statistic, thus obtaining two lists of
signiﬁcant differentially expressed genes in the BPA-treated placentas
at the two doses in comparison to controls. A total of 1220 genes were
found differently expressed with a p-value b 0.01; in particular 582
were modulated by BPA05 and 701 by BPA50; only 77 genes were
shared by the two groups (Fig. 2).
Hierarchical clustering with Euclidean distance and average linkage
was performed to discriminate between the two gene expression
proﬁles. Functional analysis of enriched GO terms and KEGG pathways
was performed to determine the biological signiﬁcance of the differen-
tially expressed genes. Transcription factor binding analysis was
performed using ﬁve different tools to minimize false positives to
identify potential gene expression regulators. Interaction networks
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calculated.
Real-time PCR was performed on critical differentially expressed
genes to validate microarray data [1].
Discussion
We describe here a data set relative to gene expression proﬁles
of mice placenta samples upon exposure to two different doses of
BPA, namely 0.5 or 50 mg/kg bw day, during early gestation (GD1–
GD11). The two doses altered two quite distinct patterns of genes
which were associated with different effects on placental morphology
and development, as supported by histological, histomorphometrical
and immunohistochemical analyses as reported in detail in [1].
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